Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Neoplasms and TNFRSF10A[original query] |
---|
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. International journal of cancer. Journal international du cancer 2006 Apr 118 (7): 1831-5. Wolf Stephan, Mertens Daniel, Pscherer Armin, Schroeter Petra, Winkler Dirk, Gröne Hermann-Josef, Hofele Christof, Hemminki Kari, Kumar Rajiv, Steineck Gunnar, Döhner Hartmut, Stilgenbauer Stephan, Lichter Pet |
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. The Prostate 2008 Feb 68 (3): 264-8. Langsenlehner Tanja, Langsenlehner Uwe, Renner Wilfried, Kapp Karin S, Krippl Peter, Hofmann Günter, Clar Heimo, Pummer Karl, Mayer Ramo |
Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jun 18 (6): 1829-40. Van Dyke Alison L, Cote Michele L, Wenzlaff Angie S, Chen Wei, Abrams Judith, Land Susan, Giroux Craig N, Schwartz Ann |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. Neoplasia (New York, N.Y.) 2011 Apr 13 (4): 386-92. Wu I-Chen, Zhao Yang, Zhai Rihong, Liu Geoffrey, Ter-Minassian Monica, Asomaning Kofi, Su Li, Liu Chen-Yu, Chen Feng, Kulke Matthew H, Heist Rebecca S, Christiani David |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: